ABYSX
Price
$24.79
Change
+$0.04 (+0.16%)
Updated
Jul 31 closing price
Net Assets
2.53B
DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
Interact to see
Advertisement

ABYSX vs DFSVX

ABYSX vs DFSVX Comparison Chart in %
View a ticker or compare two or three
VS
ABYSX vs. DFSVX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABYSX is a StrongBuy and DFSVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. ABYSX (2.53B). DFSVX pays higher dividends than ABYSX: DFSVX (1.50) vs ABYSX (0.71). ABYSX was incepted earlier than DFSVX: ABYSX (25 years) vs DFSVX (33 years). ABYSX (0.84) is less costly to investors than DFSVX (0.31). ABYSX is a more actively managed with annual turnover of: 63.00 vs. DFSVX (7.00). ABYSX (0) and DFSVX (0) have matching initial minimum investment requirements. DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. ABYSX (16.51). DFSVX return over 5 years is better than : 50.66 vs. ABYSX (-1.55).
ABYSXDFSVXABYSX / DFSVX
Total Expense Ratio0.830.31268%
Annual Report Gross Expense Ratio0.840.31271%
Fund Existence25 years33 years-
Gain YTD18.55621.33687%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.53B19.5B13%
Annual Yield % from dividends0.711.5047%
Returns for 1 year16.5134.3948%
Returns for 3 years11.7150.3723%
Returns for 5 years-1.5550.66-3%
Returns for 10 years34.30107.7132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I